{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:02:13Z","timestamp":1762527733524,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ajoc.2020.100611","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:44:53Z","timestamp":1580384693000},"page":"100611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Lisa","family":"McAnena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishan","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep S.","family":"Sagoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ashwin","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2020.100611_bib1","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100611_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100611_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajoc.2020.100611_bib4","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/bjophthalmol-2017-310294","article-title":"Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma","volume":"101","author":"Reddy","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"15","key":"10.1016\/j.ajoc.2020.100611_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.1997.03550150066037","article-title":"Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ajoc.2020.100611_bib6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jnci\/85.14.1121","article-title":"Mortality from second tumors among long-term survivors of retinoblastoma","volume":"85","author":"Eng","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100611_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ohc.2004.11.002","article-title":"Chemotherapy for retinoblastoma","volume":"18","author":"Chan","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100611_bib8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archopht.1996.01100140612015","article-title":"A new era for the treatment of retinoblastoma","volume":"114","author":"Ferris","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100611_bib9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3171\/2011.1.JNS10466","article-title":"Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors","volume":"114","author":"Peterson","year":"2011","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100611_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2011.08.045","article-title":"Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma","volume":"119","author":"Muen","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100611_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1755-3768.2011.02296.x","article-title":"Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments","volume":"91","author":"Venturi","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2020.100611_bib12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100611_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"42","key":"10.1016\/j.ajoc.2020.100611_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012676","article-title":"Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: results and short-term complications","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100611_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100611_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1591019917738962","article-title":"The technique of superselective ophthalmic artery chemotherapy for retinoblastoma: the Garrahan Hospital experience","volume":"24","author":"Requejo","year":"2018","journal-title":"Intervent Neuroradiol"},{"key":"10.1016\/j.ajoc.2020.100611_bib18","article-title":"Ophthalmic vascular events after intra-arterial chemotherapy for retinoblastoma: real-world comparison between primary and secondary treatments","author":"Ancona-Lezama","year":"2018","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100611_bib19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ophtha.2018.05.013","article-title":"Ophthalmic vascular events after primary unilateral intra-arterial chemotherapy for retinoblastoma in early and recent eras","volume":"125","author":"Dalvin","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajoc.2020.100611_bib20","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1111\/aos.13077","article-title":"Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey","volume":"94","author":"Tuncer","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100611_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/jcrt.JCRT_722_17","article-title":"Intra-arterial chemotherapy as second-line treatment for advanced retinoblastoma: a 2-year single-center study in China","volume":"14","author":"Hua","year":"2018","journal-title":"J Canc Res Therapeut"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100611_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197081","article-title":"Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival","volume":"13","author":"Francis","year":"2018","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100611_bib23","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjophthalmol-2013-303694","article-title":"Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision","volume":"97","author":"Tsimpida","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100611_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/aos.12990","article-title":"Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells","volume":"94","author":"Susskind","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100611_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1167\/iovs.18-25346","article-title":"Rabbit model of intra-arterial chemotherapy toxicity demonstrates retinopathy and vasculopathy related to drug and dose, not procedure or approach","volume":"60","author":"Daniels","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajoc.2020.100611_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jamaophthalmol.2015.2861","article-title":"Anterior segment seeding in eyes with retinoblastoma failing to respond to intraophthalmic artery chemotherapy","volume":"133","author":"Pavlidou","year":"2015","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993619300295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993619300295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:37Z","timestamp":1762527457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993619300295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"alternative-id":["S2451993619300295"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100611","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100611"}}